Cargando…
Can patient-reported outcomes be used instead of clinician-reported outcomes and photographs as primary endpoints of late normal tissue effects in breast radiotherapy trials? Results from the IMPORT LOW trial
BACKGROUND: In an era of low local relapse rates after adjuvant breast radiotherapy, risks of late normal-tissue effects (NTE) need to be balanced against risk of relapse. NTE are assessed using patient-reported outcome measures (PROMs), clinician-reported outcomes (CRO) and photographs. This analys...
Autores principales: | Bhattacharya, Indrani S., Haviland, Joanne S., Hopwood, Penelope, Coles, Charlotte E., Yarnold, John R., Bliss, Judith M., Kirby, Anna M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Scientific Publishers
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6486395/ https://www.ncbi.nlm.nih.gov/pubmed/31005219 http://dx.doi.org/10.1016/j.radonc.2019.01.036 |
Ejemplares similares
-
Patient-Reported Outcomes Over 5 Years After Whole- or Partial-Breast Radiotherapy: Longitudinal Analysis of the IMPORT LOW (CRUK/06/003) Phase III Randomized Controlled Trial
por: Bhattacharya, Indrani S., et al.
Publicado: (2019) -
Is breast seroma after tumour resection associated with patient-reported breast appearance change following radiotherapy? Results from the IMPORT HIGH (CRUK/06/003) trial
por: Bhattacharya, Indrani S., et al.
Publicado: (2019) -
Can patient decision aids reduce decisional conflict in a de-escalation of breast radiotherapy clinical trial? The PRIMETIME Study Within a Trial implemented using a cluster stepped-wedge trial design
por: Bhattacharya, Indrani S., et al.
Publicado: (2021) -
Cost-effectiveness of 5 fraction and partial breast radiotherapy for early breast cancer in the UK: model-based multi-trial analysis
por: Glynn, David, et al.
Publicado: (2022) -
Partial-breast radiotherapy after breast conservation surgery for patients with early breast cancer (UK IMPORT LOW trial): 5-year results from a multicentre, randomised, controlled, phase 3, non-inferiority trial
por: Coles, Charlotte E, et al.
Publicado: (2017)